Volume 13, Number 2—February 2007
Research
Imported Infectious Disease and Purpose of Travel, Switzerland
Lukas Fenner*1, Rainer Weber*, Robert Steffen*, and Patricia Schlagenhauf*
Table 2
Primary symptoms of persons seeking treatment at a clinic, frequent summary diagnosis, and syndrome groups in persons whose purpose of travel was visiting friends and relatives (VFR) versus traditional travelers (travelers)
| Travelers, no. (%)* | VFR, no. (%)* | |
|---|---|---|
| Primary symptom | ||
| Fever | 108 (49.76) | 57 (47.10) |
| Gastrointestinal | 117 (53.91) | 48 (39.66) |
| Head-ear-nose | 54 (24.88) | 38 (31.40) |
| Respiratory | 52 (23.96) | 34 (28.09) |
| Musculoskeletal | 25 (11.52) | 22 (18.18) |
| Skin | 30 (13.82) | 14 (11.57) |
| Fatigue | 24 (11.05) | 13 (10.74) |
| Other | 18 (8.29) | 16 (13.22) |
| Total | 428 | 242 |
| Summary diagnosis and syndrome groups | ||
| Diarrhea, acute | 79 (26.33) | 21 (11.53) |
| Respiratory infection | 40 (13.33) | 22 (12.09) |
| HIV/AIDS | 12 (4) | 15 (8.24) |
| Malaria, all species | 8 (2.67) | 14 (7.69) |
| Viral syndrome | 23 (7.67) | 10 (5.49) |
| Viral hepatitis, acute/chronic | 6 (2) | 10 (5.49) |
| Urinary tract infection | 3 (1) | 3 (1.65) |
| Febrile illness, unspecified | 10 (3.33) | 1 (0.55) |
| Dengue fever (uncomplicated) | 4 (1.33) | 1 (0.55) |
| Sexually transmitted infection | 1 (0.33) | 3 (1.65) |
| Loa loa | – | 2 (1.1) |
| Cutaneous leishmaniasis | 1 (0.33) | – |
| Typhoid/paratyphoid fever | 1 (0.33) | 1 (0.55) |
| Brucellosis | – | 1 (0.55) |
| Extraintestinal amebiasis | 1 (0.33) | –- |
| Dermatologic disorder | 22 (7.33) | 9 (4.95) |
| Chronic diarrhea | 7 (2.33) | 5 (2.75) |
| Healthy | 4 (1.33) | 2 (1.1) |
| Adverse drug or vaccine reaction | 3 (1) | 1 (0.55) |
| Cardiovascular disorder | 2 (0.67) | 3 (1.65) |
| Neurologic disorder | 2 (0.67) | 2 (1.1) |
| Lost to follow-up | 2 (0.67) | – |
| Pulmonary embolism | 1 (0.33) | 2 (1.1) |
| Psychological disorder | 1 (0.33) | 2 (1.1) |
| Death | 1 (0.33) | 1 (0.55) |
| Other diagnosis | 66 (22) | 51 (28.02) |
| Total | 300 | 182 |
*Percentage expressed as number of primary symptoms that led to a clinic visit per total patients in each group.
Page created: July 08, 2010
Page updated: July 08, 2010
Page reviewed: July 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.